Clees Therapies is categorized under Psychologist, Psychotherapist and Hypnotists in Seattle, WA and active since 1980.
Clees Therapies was established in 1980, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Psychologist, Psychotherapist and Hypnotists business, which does work in the B2C market, and is classified as a Psychologist, Psychotherapist and Hypnotists, under code number 621330 by the NAICS.
If you are seeking more information, feel free to contact David Clees at the company’s single location by writing to 2507 30th Avenue West, Seattle, Washington WA 98199 or by phoning (206) 285-6956. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clees Therapies |
| Contact Person: | David Clees |
| Address: | 2507 30th Avenue West, Seattle, Washington 98199 |
| Phone Number: | (206) 285-6956 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 1980 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Psychologist, Psychotherapist and Hypnotists |
| SIC Code: | 8049 |
| NAICS Code: | 621330 |
| Share This Business: |
Clees Therapies was started in 1980 to provide professional Psychologist, Psychotherapist and Hypnotists under the SIC code 8049 and NAICS code 621330. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact David Clees for inquiries that concern Clees Therapies by calling the company number (206) 285-6956, as your correspondence is most welcome. Additionally, the physical location of the single location of Clees Therapies can be found at the coordinates 47.641477,-122.395861 as well as the street address 2507 30th Avenue West in Seattle, Washington 98199.
For its online presence, you may visit Clees Therapies’s website at and engage with its social media outlets through on Twitter and on Facebook.